Imatinib Mesylate & Death
45.7%
of users reported Death
94.3%
also reported Death
75.0%
are men
Most common medical consequences
Death
94.3%
Severe reaction
5.7%
Have you experienced any negative side effects from this medication?
Imatinib Mesylate: general information
Most common side effects (4)
Most commonly affected ages
40 - 49 years
17.6%
50 - 59 years
<0.1%
60 - 69 years
22.5%
70 - 79 years
59.8%
Stay safe!
Get the latest drug safety information, personalized and delivered straight to your inbox